Axon cytoskeleton ultrastructure in chronic inflammatory demyelinating polyneuropathy

Muscle and Nerve

Volumn 44, Issue 3, 2011, Pages 332-339

  Fressinaud, Catherine ^a,b   Dubas, Frederic ^a,b  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ D'ANGERS   (France)

Author keywords

Axonal cytoskeleton; CIDP; GAP 43; Microtubule; Neurofilament

Indexed keywords

GROWTH ASSOCIATED PROTEIN; MYELIN;

ADULT; ANTIBODY LABELING; ARTICLE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSKELETON; DISEASE SEVERITY; HUMAN; NERVE BIOPSY; NERVE FIBER; NERVE LESION; NEUROFILAMENT; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

AGED; AXONS; BIOPSY; CASE-CONTROL STUDIES; CYTOSKELETON; FEMALE; GAP-43 PROTEIN; HUMANS; MALE; MICROTUBULES; MIDDLE AGED; MYELIN SHEATH; NEUROFIBRILS; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; SEVERITY OF ILLNESS INDEX;

EID: 80052040773     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.22069     Document Type: Article

References (35)

1. McLeod JG, Pollard JD, Macaskill P, Mohammed A, Spring P, Khur-ana V. Prevalence of chronic inflammatory demyelinating neuropathy in New South Wales, Australia. Ann Neurol 1999;46:910-913.
2. Vallat JM, Tabaraud F, Magy L, Torney F, Bernet-Bernady P, Macian F, et al. Diagnostic value of nerve biopsy for atypical chronic inflam-matory demyelinating polyneuropathy: evaluation of eight cases. Muscle Nerve 2003;27:478-485.
3. Bosboom WM, van den Berg LH, Franssen H, Giesbergen PC, Flach HJ, van Putten AM, et al. Diagnostic value of sural nerve demyelin-ation in chronic inflammatory demyelinating polyneuropathy. Brain 2001;124:2427-2438.
4. Rentzos M, Anyfanti C, Kaponi A, Pandis D, Ioannou M, Vassilopou-los D. Chronic inflammatory demyelinating polyradiculoneuropathy: a 6-year retrospective clinical study of a hospital-based population. J Clin Neurosci 2007;14:229-235.
5. European Federation of Neurological Societies Task Force. Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 2006;13:326-332.
6. Kosky CL, Baumgarten M, Magder LS, Barohn RJ, Goldstein J, Graves M, et al. Derivation and validation of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 2009;277:1-8.
7. Azulay JPH, Pouget J, Pellissier JF, Blin O, Serratrice G. Polyradiculo-névrites chroniques: 25 cas. Rev Neurol (Paris) 1992;148:752-761.
8. Haq RU, Fries TJ, Pendlebury WW, Kenny MJ, Badger GJ, Tandan R. Chronic inflammatory demyelinating polyradiculoneuropathy. A study of proposed electrodiagnostic and histologic criteria. Arch Neurol 2000;57:1745-1750.
9. Prineas JW, Mcleod JG. Chronic relapsing polyneuritis. J Neurol Sci 1976;27:427-458.
10. Julien J, Vital C, Lagueny A, Ferrer X, Brechenmacher C. Chronic relapsing idiopathic polyneuropathy with primary axonal lesions. J Neurol Neurosurg Psychiatry 1989;52:871-875.
11. Hughes RAC, Allen D, Makowska A, Gregson N. Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy. J Periph Nerv Syst 2006;11:30-46.
12. Krajewski KM, Lewis RA, Fuerst DR, Turanski C, Hinderer SR, Gar-bern J, et al. Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. Brain 2000;123:1516-1527.
13. Nagamatsu M, Terao S, Misu K, Li M, Hattori M, Ichimura M, et al. Axonal and perikaryal involvement in chronic inflammatory demyeli-nating neuropathy. J Neurol Neurosurg Psychiatry 1999;66:727-733.
14. Lunn MPT, Crawford TO, Hughes RAC, Griffin JW, Sheikh KA. Anti-myelin-associated glycoprotein antibodies alter neurofilament spacing. Brain 2002;125:904-911.
15. Save MP, Shetty VP, Shetty KT, Antia NH. Alterations in neurofila-ment protein(s) in human leprous nerves: morphology, immunohis-tochemistry and Western immunoblot correlative study. Neuropathol Appl Neurobiol 2004;30:635-650.
16. Sobue G, Li M, Terao S, Aoki S, Ichimura M, Ieda T, et al. Axonal pathology in Japanese Guillain-Barré syndrome: a study of 15 autop-sied cases. Neurology 1997;48:1694-1700.
17. Pillai AM, Thaxton C, Pribisko AL, Cheng JG, Dupree JL, Bhat MA. Spatiotemporal ablation of myelinating glia-specific neurofascin (Nfasc NF 155) in mice reveals gradual loss of paranodal axoglial junctions and concomitant disorganization of axonal domains. J Neurosci Res 2009;87:1773-1793.
18. Jean I, Allamargot C, Barthelaix-Pouplard A, Fressinaud C. Axonal lesions and PDGF enhanced remyelination in the rat corpus cal-losum after lysolecithin demyelination. Neuroreport 2002;13: 627-631.
19. Hoffman PN, Cleveland DW. Neurofilament and tubulin expression recapitulates the developmental program during axonal regeneration: induction of a specific b-tubulin isotype. Proc Natl Acad Sci USA 1988;85:4530-4533.
20. Fressinaud C, Jean I. Polyradiculonévrites inflammatoires chroniques et cytosquelette axonal: donné es morphométriques et immunocyto-chimiques. Rev Neurol (Paris) 2002;158:713-718.
21. Fressinaud C, Vallat JM, Rigaud M, Leboutet MJ. Analysis of unsatu-rated fatty acids of endoneurium and perineurium from normal and degenerating rat sciatic nerve. Morphological correlations. J Neurol Sci 1987;81:85-92.
22. Behse F. Morphometric studies on the human sural nerve.Acta Neu-rol Scand 1990;82(suppl):132.
23. Thomas PK. The quantitation of nerve biopsy findings. J Neurol Sci 1970;11:285-295.
24. Vital C, Vallat JM, editors. Morphometric features. In: Ultrastructural study of the human diseased peripheral nerve. New York: Elsevier; 1987. p 21-22.
25. Vallat JM, Magy L, Richard L, Sturtz F, Couratier P. Contribution of electron microscopy to the study of neuropathies associated with an IgG monoclonal paraproteinemia. Micron 2008;39:61-70.
26. Said G. Chronic inflammatory demyelinating polyneuropathy. Neu-romuscular disorders 2006;16:293-303.
27. Coman I, Aigrot MS, Seilhean D, Reynolds R, Girault JA, Zalc B, et al. Nodal, paranodal and juxtanodal axonal proteins during demy-elination and remyelination in multiple sclerosis. Brain 2006;129: 3186-3195.
28. Fressinaud C, Jean I, Dubas F. Modifications des neurofilaments et des microtubules axonaux en fonction du mécanisme lésionnel: étude pathologique et expérimentale. Rev Neurol (Paris) 2005;161:55-60.
29. Jiang XM, Zhao JX, Ohnishi A, Itakura C, Mizutani M, Yamamoto T, et al. Regeneration of myelinated fiber after crush injury is retarded in sciatic nerves of mutant Japanese quails deficient in neurofila-ments. Acta Neuropathol (Berl) 1996;92:467-472.
30. Jean I, Fressinaud C. Spontaneous central nervous system remyelina-tion is not altered in NFH-lacZ transgenic mice after chemical demy-elination. J Neurosci Res 2003;73:54-60.
31. Friede RL, Samorajski T. Axon caliber related to neurofilaments and microtubules in sciatic nerve fibers of rats and mice. Anat Rec 1970; 167:379-388.
32. Yamasaki H, Itakura C, Mizutani M. Hereditary hypotrophic axonop-athy with neurofilament deficiency in a mutant strain of Japanese quail. Acta Neuropathol 1991;82:427-434.
33. Fressinaud C, Vigneron I, Letournel F, Nicolas G, Jean I, Dubas F. Cytoskeleton abnormalities in axonopathies of unknown aetiology: correlations with morphometry. J Neurol Sci 2002;196:53-61.
34. Parhad IM, Clark AW, Griffin JW. Effect of changes in neurofilament content on caliber of small axons: the β,β'-iminodipropionitrile model. J Neurosci 1987;7:2256-2263.
35. Fressinaud C, Jean I, Dubas F. Selective decrease in axonal nerve growth factor and insulin-like growth factor I immunoreactivity in axonopathies of unknown etiology. Acta Neuropathol (Berl) 2003; 105:477-483.